JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1992; 19:1542-1549
© 1992 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hesselson, A.
Right arrow Articles by Bonavita, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hesselson, A.
Right arrow Articles by Bonavita, G.

Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing

AB Hesselson, V Parsonnet, AD Bernstein, and GJ Bonavita

Pacemaker Center, Newark Beth Israel Medical Center, New Jersey 07112.

Nine hundred fifty patients who received three modes of primary pacemaker systems (581 dual-chamber universal [DDD], 84 atrioventricular-sequential ventricular-inhibited [DVI] and 285 ventricular-inhibited [VVI]) over 12 years were studied retrospectively to determine the effect of pacing mode on patient longevity and the subsequent development of chronic atrial fibrillation or flutter. All patients were followed up continuously for 7 to 8 years. Patients were classified according to indication for permanent pacing (sick sinus syndrome or other indication), age at pacemaker implantation (less than or equal to 70 or greater than 70 years) and history of atrial tachyarrhythmia. Fourteen percent of patients developed atrial fibrillation at some time during the study period. Of those, 4% had a DDD pacemaker, 8% had a DVI pacemaker and 19% had a VVI pacemaker. At 7 years, atrial fibrillation was significantly more frequent in the VVI group than in the DDD and DVI groups. In patients with sick sinus syndrome, the incidence rate was even higher in the VVI group but approximately the same in the DDD and DVI groups. Patients in the VVI and DVI groups who had had previous atrial tachyarrhythmia had a significantly higher incidence of atrial fibrillation at 7 years than did those in the DDD group. During the entire period there were 130 deaths in the study group, including 22% of patients with a DDD pacemaker, 38% of those with a DVI pacemaker and 50% of those with a VVI pacemaker. Patient survival at 7 years was lower in the VVI group than in the DDD or DVI groups.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
JAMAHome page
Z. Goldberger and R. Lampert
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
JAMA, February 15, 2006; 295(7): 809 - 818.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. W. Israel
The role of pacing mode in the development of atrial fibrillation.
Europace, February 1, 2006; 8(2): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Walker, S. C. Siu, S. Woods, D. A. Cameron, G. D. Webb, and L. Harris
Long-Term outcomes of cardiac pacing in adults with congenital heart disease
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1894 - 1901.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. A. Lamas, K. A. Ellenbogen, and With the Assistance of Charles H. Hennekens, MD, D
Evidence Base for Pacemaker Mode Selection: From Physiology to Randomized Trials
Circulation, February 3, 2004; 109(4): 443 - 451.
[Full Text] [PDF]


Home page
EuropaceHome page
A. Quesada, J.ús Almendral, F. Arribas, R. Ricci, C. Wolpert, P. Adragao, E. Cobo, X. Navarro, and on behalf DATAS investigators
The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator
Europace, January 1, 2004; 6(2): 142 - 150.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Masumoto, Y. Ueda, R. Kato, A. Usui, T. Maseki, Y. Takagi, and M. Usui
Long-term clinical performance of AAI pacing in patients with sick sinus syndrome: a comparison with dual-chamber pacing
Europace, January 1, 2004; 6(5): 444 - 450.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. D. Carlson, J. Ip, J. Messenger, S. Beau, S. Kalbfleisch, P. Gervais, D. A. Cameron, A. Duran, J. Val-Mejias, J. Mackall, et al.
A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT)
J. Am. Coll. Cardiol., August 20, 2003; 42(4): 627 - 633.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Santini and R. Ricci
Atrial fibrillation and heart failure
Europace, January 1, 2003; 5(s1): S55 - S59.
[Full Text] [PDF]


Home page
NEJMHome page
J. M. Cooper, M. S. Katcher, and M. V. Orlov
Implantable Devices for the Treatment of Atrial Fibrillation
N. Engl. J. Med., June 27, 2002; 346(26): 2062 - 2068.
[Full Text] [PDF]


Home page
NEJMHome page
G. A. Lamas, K. L. Lee, M. O. Sweeney, R. Silverman, A. Leon, R. Yee, R. A. Marinchak, G. Flaker, E. Schron, E. J. Orav, et al.
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
N. Engl. J. Med., June 13, 2002; 346(24): 1854 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Padeletti, P. Pieragnoli, C. Ciapetti, A. Colefa, N. Musilli, M.C. Porciani, A. Michelucci, and G.F. Gensini
Prevention of paroxysmal atrial fibrillation by permanent septal atrial pacing: long-term follow up
Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P2 - P6.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
G. Boriani, M. Biffi, L. Padeletti, A. Sparnpinato, G. Luca Botto, C. Pignalberi, A. Grammatico, D.A. Hettrick, F. De Seta, and A. Branzi
Effects of consistent atrial pacing and atrial rate stabilization - two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome
Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P7 - P15.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
A. C. Skanes, A. D. Krahn, R. Yee, G. J. Klein, S. J. Connolly, C. R. Kerr, M. Gent, K. E. Thorpe, R. S. Roberts, and for the CTOPP Investigators
Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 167 - 172.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. J. Ward, J. E. Willett, C. Bucknall, J. S. Gill, and K. Kamalvand
Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment
Europace, January 1, 2001; 3(2): 108 - 114.
[Abstract] [PDF]


Home page
NEJMHome page
S. J. Connolly, C. R. Kerr, M. Gent, R. S. Roberts, S. Yusuf, A. M. Gillis, M. H. Sami, M. Talajic, A. S.L. Tang, G. J. Klein, et al.
Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes
N. Engl. J. Med., May 11, 2000; 342(19): 1385 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. K. Chung, R. S. Augostini, C. R. Asher, D. P. Pool, T. A. Grady, M. Zikri, S. M. Buehner, M. Weinstock, and P. M. McCarthy
Ineffectiveness and potential proarrhythmia of atrial pacing for atrial fibrillation prevention after coronary artery bypass grafting
Ann. Thorac. Surg., April 1, 2000; 69(4): 1057 - 1063.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Gillis, D. G. Wyse, S. J. Connolly, M. Dubuc, F. Philippon, R. Yee, P. Lacombe, M. S. Rose, and C. D. Kerr
Atrial Pacing Periablation for Prevention of Paroxysmal Atrial Fibrillation
Circulation, May 18, 1999; 99(19): 2553 - 2558.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Jahangir, W.-K. Shen, S. A. Neubauer, D. J. Ballard, S. C. Hammill, D. O. Hodge, C. M. Lohse, B. J. Gersh, and D. L. Hayes
Relation between mode of pacing and long-term survival in the very elderly
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1208 - 1216.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. M. McComb and G. M. Gribbin
Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: Determinants and treatment
Europace, January 1, 1999; 1(1): 30 - 34.
[Abstract] [PDF]


Home page
EuropaceHome page
A. M. Gillis
The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study: Rationale and study design
Europace, January 1, 1999; 1(1): 40 - 42.
[Abstract] [PDF]


Home page
HeartHome page
H J MARSHALL, M D GAMMAGE, and M J GRIFFITH
AAI pacing for sick sinus syndrome: first choice on all counts
Heart, October 1, 1998; 80(4): 315 - 316.
[Full Text]


Home page
CirculationHome page
H. R. Andersen, J. C. Nielsen, P. E. B. Thomsen, L. Thuesen, T. Vesterlund, A. K. Pedersen, and P. T. Mortensen
Atrioventricular Conduction During Long-Term Follow-Up of Patients With Sick Sinus Syndrome
Circulation, September 29, 1998; 98(13): 1315 - 1321.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G M Gribbin, J P Bourke, and J M McComb
Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias
Heart, June 1, 1998; 79(6): 548 - 553.
[Abstract] [Full Text]


Home page
NEJMHome page
G. A. Lamas, E. J. Orav, B. S. Stambler, K. A. Ellenbogen, E. B. Sgarbossa, S. K. S. Huang, R. A. Marinchak, N.A. M. Estes, G. F. Mitchell, E. H. Lieberman, et al.
Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing
N. Engl. J. Med., April 16, 1998; 338(16): 1097 - 1104.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. W. Mason and M. A. Hlatky
Do Patients Prefer Physiologic Pacing?
N. Engl. J. Med., April 16, 1998; 338(16): 1146 - 1148.
[Full Text]


Home page
HeartHome page
D J R Hildick-Smith, M D Lowe, S A Newell, P M Schofield, L M Shapiro, D L Stone, A A Grace, and M C Petch
Ventricular pacemaker upgrade: experience, complications and recommendations
Heart, April 1, 1998; 79(4): 383 - 387.
[Abstract] [Full Text]


Home page
HeartHome page
C.-P. Lau, H.-F. Tse, and G. Cheng
Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients
Heart, October 1, 1997; 78(4): 358 - 363.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Papageorgiou, F. Anselme, C. J. H. J. Kirchhof, K. Monahan, C. A. F. Rasmussen, L. M. Epstein, and M. E. Josephson
Coronary Sinus Pacing Prevents Induction of Atrial Fibrillation
Circulation, September 16, 1997; 96(6): 1893 - 1898.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Alboni, C. Menozzi, M. Brignole, N. Paparella, G. Gaggioli, G. Lolli, and R. Cappato
Effects of Permanent Pacemaker and Oral Theophylline in Sick Sinus Syndrome : The THEOPACE Study: A Randomized Controlled Trial
Circulation, July 1, 1997; 96(1): 260 - 266.
[Abstract] [Full Text]


Home page
CirculationHome page
G. A. Lamas, C. L. Pashos, S.-L. T. Normand, and B. McNeil
Permanent Pacemaker Selection and Subsequent Survival in Elderly Medicare Pacemaker Recipients
Circulation, February 15, 1995; 91(4): 1063 - 1069.
[Abstract] [Full Text]


Home page
JWatch GeneralHome page
ARE DUAL-CHAMBER PACEMAKERS SAFER
Journal Watch (General), June 16, 1992; 1992(616): 6 - 6.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1992 by the American College of Cardiology Foundation.